Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of GLH8NDE in Patients With Dry Eye Disease
Status:
Not yet recruiting
Trial end date:
2022-04-30
Target enrollment:
Participant gender:
Summary
This study is a randomized, double-blind, placebo-controlled phase 2 clinical trial to
evaluate the efficacy and safety of GLH8NDE in patients with Dry Eye Disease.